Canada markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7400+0.0100 (+0.58%)
At close: 04:00PM EDT
1.7200 -0.02 (-1.15%)
After hours: 07:35PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
277,788
116,334
75,475
78,447
227,547
Cost of Revenue
50,513
43,267
26,967
14,217
2,392
Gross Profit
227,275
73,067
48,508
64,230
225,155
Operating Expenses
Research Development
57,491
86,107
118,927
105,975
146,936
Selling General and Administrative
164,836
142,523
109,082
184,985
199,615
Total Operating Expenses
222,327
228,630
228,009
290,960
346,551
Operating Income or Loss
4,948
-155,563
-179,501
-226,730
-121,396
Interest Expense
57,799
58,976
56,810
46,353
22,670
Total Other Income/Expenses Net
-45,646
5,291
2,652
3,975
515
Income Before Tax
-98,497
-209,248
-233,659
-269,108
-143,551
Income from Continuing Operations
-98,497
-209,248
-233,659
-269,108
-143,551
Net Income
-98,497
-209,248
-233,659
-269,108
-143,551
Net Income available to common shareholders
-98,497
-209,248
-233,659
-269,108
-143,551
Basic EPS
-9.31
-2.03
-3.52
-9.31
-5.23
Diluted EPS
-9.31
-2.03
-3.52
-9.31
-5.23
Basic Average Shares
28,903
103,107
66,407
28,903
27,474
Diluted Average Shares
28,903
103,107
66,407
28,903
27,474